Last update :
19/11/2024
References   References 3963  
Type : Journal
Web link : http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=4297

Research teams : Bondy - University Hospital Jean Verdier, Department of Pharmacy
Authors : Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J.
Title : Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Reference : Int J Pharm Compound ; 21, 2: 160-163. 2017

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionHydroxyurea Anticancer drug
Stability in solutions Glass powder 6000 mg
® = Inresa
OraPlus® / OraSweet® (1:1) >> 60 mL
22-25°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
OraPlus® / OraSweet SF® (1:1) >> 60 mL
22-25°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
Orablend® >> 60 mL
22-25°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
Orablend SF® >> 60 mL
22-25°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
OraPlus® / OraSweet® (1:1) >> 60 mL
4-8°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
OraPlus® / OraSweet SF® (1:1) >> 60 mL
4-8°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
Orablend® >> 60 mL
4-8°C Protect from light
120 Day
Stability in solutions Glass powder 6000 mg
® = Inresa
Orablend SF® >> 60 mL
4-8°C Protect from light
120 Day

  Mentions Légales